Low uptake of antiretroviral therapy after admission with human immunodeficiency virus and tuberculosis in KwaZulu-Natal, South Africa.
AffiliationDoctors Without Borders USA, New York, USA; McCord Hospital, South Africa; Harvard Medical School, Massachusetts, USA; Division of Infectious Disease and Geographic Medicine, California, USA; Zoe-Life, South Africa; Section of Retroviral Therapeutics, Massachusetts, USA; Centre for Biostatistics in AIDS Research, Massachusetts, USA
MetadataShow full item record
AbstractA prospective cohort study was conducted among human immunodeficiency virus (HIV) infected in-patients with tuberculosis (TB) or other opportunistic infections (OIs) in South Africa to estimate subsequent antiretroviral therapy (ART) uptake and survival.
- Operationalizing early antiretroviral therapy in HIV-infected in-patients with opportunistic infections including tuberculosis.
- Authors: Sunpath H, Edwin C, Chelin N, Nadesan S, Maharaj R, Moosa Y, Smeaton L, Court R, Knight S, Gwyther E, Murphy RA
- Issue date: 2012 Jul
- Immune recovery after starting ART in HIV-infected patients presenting and not presenting with tuberculosis in South Africa.
- Authors: Schomaker M, Egger M, Maskew M, Garone D, Prozesky H, Hoffmann CJ, Boulle A, Fenner L, IeDEA Southern Africa.
- Issue date: 2013 May 1
- Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.
- Authors: Lawn SD, Myer L, Edwards D, Bekker LG, Wood R
- Issue date: 2009 Aug 24
- HIV-related symptoms and management in HIV and antiretroviral therapy patients in KwaZulu-Natal, South Africa: a longitudinal study.
- Authors: Peltzer K
- Issue date: 2013
- Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa.
- Authors: Lawn SD, Myer L, Bekker LG, Wood R
- Issue date: 2007 Jan 30